Background: A picosecond laser irradiation technique has presented satisfactory cosmetic outcomes for the treatment of various pigmented lesions.We aimed to evaluate the clinical results of a picosecond neodymiumdoped:yttrium aluminum garnet (Nd:YAG) (PSNY) laser for the treatment of various pigmented lesions and to compare them with the results of a conventional Q-switched Nd:YAG laser.Methods: A retrospective review of subjects treated with a PSNY laser was performed.Clinical improvement was assessed by two blinded dermatologists using a 5-point Global Assessment Scale (GAS).Adverse events were also assessed.Results: Forty-eight patients were treated with a dual-wavelength (532-nm and/or 1,064-nm) PSNY laser.Sixteen of the 48 patients (33.3%) experienced more than 50% improvement after the PSNY treatment.Patients with café-au-lait macule showed the greatest improvement, which was fair to good (GAS, 3.80 ± 0.76).Patients with postinflammatory hyperpigmentation received the highest number of treatment sessions (6.60 ± 3.44 times).The duration of follow-up was the longest in patients with Ota's nevus (22.50 ± 5.44 weeks).There were no serious complications during the treatment period. Conclusion:In our case series, it was concluded that a dual-wavelength 532-nm and 1,064-nm PSNY laser was safe and effective for the treatment of pigmented lesions in Korean patients.
No takes yet. Share an insight, caveat, or question.
Byun et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: